Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts.

about

Vulvovaginal pyoderma gangrenosum in association with rituximab

P2860

Q57297958-0C835ACA-0369-4D58-B69A-0496F8BD3B02

P2860

Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts.

Item

http://www.wikidata.org/entity/Q41243953

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts.

@en

type

Item

label

Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts.

@en

prefLabel

Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts.

@en

P1476

Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts.

@en

P2093

Joachim Dissemond

http://www.w3.org/2001/XMLSchema#string

Philipp Al Ghazal

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients

Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions.

An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases.

Skin ulcers misdiagnosed as pyoderma gangrenosum.

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.

Pyoderma gangrenosum of the breast treated with intravenous immunoglobulin

Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients.

Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.

Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.

P304

317-324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DDG.12585_SUPPL

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274142398

http://www.w3.org/2001/XMLSchema#string

P698

25761564

http://www.w3.org/2001/XMLSchema#string

P921

A' Ghearmailt

Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts.

about

P2860

P2860

Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921